Research

Swim Across America Celebrates 10 Years in the Baltimore Area

Swim Across America Celebrates 10 Years in the Baltimore Area

Posted by  | Giving Back, Research

Celebrating a decade of support for groundbreaking cancer research, Swim Across America-Baltimore brings together swimmers of all ages and skill levels, including Olympians, with grassroots fundraising. Making a splash in Maryland 10 years ago, the organization has donated $3.4 million to the Johns Hopkins Sidney Kimmel Cancer Center for clinical trials in immunotherapy, genomic-based testing(...)

Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention

Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention

Posted by  | Issues & Perspectives, Research

A national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019. Elizabeth Platz, M.P.H., Sc.D, is the co-leader for cancer prevention and control at the Johns Hopkins Kimmel Cancer Center. She was named as editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention (CEBP), one of(...)

Pancreatic Cancer Matters: Right Treatment at the Right Time

Pancreatic Cancer Matters: Right Treatment at the Right Time

Posted by  | Issues & Perspectives, pancreatic cancer, precision medicine, Research, treatment

Our collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory into exceptional clinical care. The Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care is a world leader in the diagnosis and management of pancreatic cancer, leading all(...)

The Future of Pancreatic Cancer Treatments

The Future of Pancreatic Cancer Treatments

Posted by  | Issues & Perspectives, pancreatic cancer, Prevention/Screening, Research, treatment

Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly

Three Minutes with Oncologist Michael Carducci

Three Minutes with Oncologist Michael Carducci

Posted by  | caregiving, Issues & Perspectives, palliative care, Research

Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for the Greater Washington, D.C., area for the Kimmel Cancer Center. In his many years as an oncologist, Carducci has expertise in various types of cancer including bladder, kidney, prostate and(...)

Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors

Posted by  | Research

Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the(...)

Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options

Posted by  | Research, treatment

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may(...)

NSCLC Treatment Gets Specific with Next-Gen Sequencing, Cell-Free DNA

Posted by  | Research

During a presentation on advanced non-small cell lung cancer (NSCLC), Ben Levy, M.D., a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, said there is a new opportunity for clinicians to be more specific when targeting mutations in those cancer patients.(...)

Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Posted by  | Issues & Perspectives, Research, Survivorship

Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention(...)

Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers

Posted by  | Issues & Perspectives, Prevention/Screening, Research

Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the(...)